Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$27.3K
8.69K shares
What this filing means
JAMIL KHURRAM plans to sell 8.69K shares of GALECTIN THERAPEUTICS INC valued at approximately $27.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001972481-26-000208
Officer· Chief Medical Officer
Since Aug 2024
8.69K
Shares to sell
$27.3K
Approx. market value
8.13K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/23/2025
8.13KTotal acquired8.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Stock Option Exercise Cash | 8.13K | — |
| Total | 8.13K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
568.00
Market value
$1.8K
5/26/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
8.13K
Market value
$25.5K
6/23/2026
Total
Units
8.69K
Value
$27.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 568.00 | $1.8K | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 8.13K | $25.5K | Nasdaq | Planned |
| Total | 8.69K | $27.3K | ||